about
Antipyretic drug use in children in French office based medical practiceAutoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects.Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome.Childhood immune thrombocytopenia: A nationwide cohort study on condition management and outcomes.Who seeks primary care for musculoskeletal disorders (MSDs) with physicians prescribing homeopathic and other complementary medicine? Results from the EPI3-LASER survey in France.Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT projectBenchmarking clinical management of spinal and non-spinal disorders using quality of life: results from the EPI3-LASER survey in primary care.Management of upper respiratory tract infections by different medical practices, including homeopathy, and consumption of antibiotics in primary care: the EPI3 cohort study in France 2007-2008Benchmarking the burden of 100 diseases: results of a nationwide representative survey within general practicesHomeopathic medical practice for anxiety and depression in primary care: the EPI3 cohort studyModel-observational bridging study on the effectiveness of ezetimibe on cardiovascular morbidity and mortality in France: A population-based study.Antiepileptic drugs and risk of suicide attempts: a case-control study exploring the impact of underlying medical conditions.Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD).Who seeks primary care for sleep, anxiety and depressive disorders from physicians prescribing homeopathic and other complementary medicine? Results from the EPI3 population survey.Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses.Impact of allopurinol on risk of myocardial infarction.Utilization of psychotropic drugs by patients consulting for sleeping disorders in homeopathic and conventional primary care settings: the EPI3 cohort study.Does omalizumab make a difference to the real-life treatment of asthma exacerbations?: Results from a large cohort of patients with severe uncontrolled asthma.Effect of an Institutional Medication Adherence Program for Long-Acting Injectable Risperidone on Adherence and Psychiatric Hospitalizations: Evidence from a Prospective Cohort Study.Characteristics of patients consulting their regular primary care physician according to their prescribing preferences for homeopathy and complementary medicine.The risk of acute liver injury associated with the use of antibiotics--evaluating robustness of results in the pharmacoepidemiological research on outcomes of therapeutics by a European consortium (PROTECT) project.Heptavalent pneumococcal conjugate vaccine (PCV7): French survey of serious adverse reactions.Multi-centre, multi-database studies with common protocols: lessons learnt from the IMI PROTECT project.The IMI PROTECT project: purpose, organizational structure, and procedures.Isotretinoin exposure during pregnancy: assessment of spontaneous reports in France.Clinical features and risk factors for upper gastrointestinal bleeding in children: a case-crossover study.Risk of breast cancer by individual insulin use: an international multicenter study.Reply to: Comments on "Agreement between patients' self-report and physicians' prescriptions on non-steroidal anti-inflammatory drugs and other drugs used in musculoskeletal disorders".Agreement between patients' self-report and physicians' prescriptions on cardiovascular drug exposure: the PGRx database experience.Risk of ST versus non-ST elevation myocardial infarction associated with non-steroidal anti-inflammatory drugs.Agreement between patients' self-report and physicians' prescriptions on nonsteroidal anti-inflammatory drugs and other drugs used in musculoskeletal disorders: the international Pharmacoepidemiologic General Research eXtension database.Clinical and economic burden of severe asthma: A French cohort studyThe international study of insulin and cancerDronedarone, amiodarone and other antiarrhythmic drugs, and acute liver injuries: a case-referent studyThe systematic case-referent method
P50
Q28212308-EBE74349-C979-41F3-8F17-EAB615A72B48Q33411345-3DCFCF22-1FC4-4234-986E-4AA8F421D233Q33432523-92240A61-5ED0-4362-8DB4-901C1C040B26Q33437268-F4BF5EFF-1602-429F-8F3A-4B55DC45FA89Q33797384-C613F14D-DA19-437C-8DD5-0D5CA515CDF6Q33851671-0172EB57-55A7-4E2F-9DD6-A5BBEA731753Q33871083-7DF86BBF-450F-4035-9906-9C191169F026Q35124850-DB951D6E-914C-4022-924E-73D3EAD7F92EQ35564892-DC137234-88C2-4DCB-A29F-FCEA9751F772Q36008600-22C82306-3158-486B-975B-9863FAF8CA9AQ36213743-E76E9E4B-1485-47F3-8CA7-BFE68D34AFE6Q36239710-E95BE63C-A9D8-4A55-A144-AB053E85642CQ36472011-5CEFE684-64DE-43B5-B823-DFBC2058C058Q36496179-91072981-D092-4DC1-8BCF-9E79E6957963Q38438386-61D0B267-D7B0-4C8B-A40B-3D60DBD740F9Q39033643-78B771AB-295A-4073-8328-165596477A81Q39033648-85CE7C1C-DF2B-4C3D-B8DA-AB7A80572740Q39033654-8A071F7B-3C47-4AF3-91AE-E05046E450BBQ39099925-3A480EA4-0A0C-411C-B130-0A1D38D42EAAQ39171853-200B79A9-A85C-481B-9A3C-4ACAAEB11F68Q39540384-8A9EE9B3-C411-4279-9F9F-BB7524D8E95FQ39763667-56F65BC0-2D7E-4D07-A5EC-E53F0F3EC045Q39869491-41F6FA0D-FC59-448C-9D8A-4A5035E93DF9Q39869520-13C89F87-A03E-4CA8-9492-8A51ED7F0EB9Q42968503-FE45F63F-537A-4C59-80C3-D7BA3BA3B2FCQ43062021-48602C93-4ABE-4802-9560-0B935B687CD4Q43892599-FF8D9CB1-44EB-4DD1-AAB5-34C6E54AD7E7Q44483121-3CD90889-BC20-4DF7-8968-016E6FD7387DQ45012338-BDD51E09-76D5-438B-ABBD-F6E737EB0223Q51535809-A0FE3FBF-9A2D-47A6-A051-BEF23849A95AQ53095404-E0BE6E09-1520-4A59-8078-E0F1043AE0BCQ58085296-60D98FF5-A0A1-44EB-8368-749EEB9EFABCQ84979157-4B784E81-5F1C-47B3-825D-ED085D377F17Q89055375-0B5A3DF7-10DD-4A41-8FF3-29E5F800B02CQ93334373-E67F5495-2095-4093-AFEA-167F8BDF5CF6
P50
description
researcher ORCID ID = 0000-0003-1952-5467
@en
wetenschapper
@nl
name
L Grimaldi-Bensouda
@ast
L Grimaldi-Bensouda
@en
L Grimaldi-Bensouda
@es
L Grimaldi-Bensouda
@nl
type
label
L Grimaldi-Bensouda
@ast
L Grimaldi-Bensouda
@en
L Grimaldi-Bensouda
@es
L Grimaldi-Bensouda
@nl
prefLabel
L Grimaldi-Bensouda
@ast
L Grimaldi-Bensouda
@en
L Grimaldi-Bensouda
@es
L Grimaldi-Bensouda
@nl
P1153
36019935800
P31
P496
0000-0003-1952-5467